PD-1 drugs for Cervical Cancer

5 tracked PD-1 drugs in the Cervical Cancer race. The class explanation lives on the PD-1 page; the full indication pipeline across every mechanism is on the Cervical Cancer page.

2 approved / phase 41 Phase 31 Phase 2/31 Phase 2

Head-to-head evidence: Balstilimab vs Pembrolizumab · Camrelizumab vs Pembrolizumab · Enlonstobart vs Pembrolizumab · Pembrolizumab vs Pembrolizumab berahyaluronidase alfa

The roster

← all PD-1 drugs